drugset / Trial / NCT03197324

Bexagliflozin Drug/Drug Interaction Study With Digoxin

NCT03197324

Phase 1 Completed 20 enrolled Theracos
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to examine the drug-drug interaction in your body when given the study drug, bexagliflozin, with the heart failure medication digoxin. The study will evaluate whether bexagliflozin effects the amount of digoxin in your blood and how safe the study drug is and how well the study drug is tolerated when taken with digoxin.

Timeline

Start
2017-07-24
Primary completion
2017-09-17
Completion
2017-09-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bexagliflozin Small molecule 20 mg Oral
Comparator Digoxin Other / unclassified 0.5 mg Oral